Home / Market News / $CAL
benzinga Corporate Catalyst Impact 92/100 ● positive

Caleres Posts Upbeat Q2 Earnings, Joins Opus Genetics, Flotek Industries And Other Big Stocks Moving Higher On Wednesday

Sep 9, 2026, 2:04 PM UTC · Primary ticker $CAL

Caleres Inc. (CAL) reported better-than-expected second-quarter financial results, surpassing both EPS and sales consensus estimates. The company also raised its FY26 EPS guidance, leading to a significant jump in its stock price despite a broader market downturn.

This filing primarily discloses Caleres Inc.'s strong second-quarter performance, where it exceeded analyst expectations for both earnings per share and sales. Crucially, the company also increased its FY26 EPS guidance, signaling confidence in future profitability. This positive corporate catalyst led to a significant 14.4% surge in CAL's stock price, even as the broader market experienced a downturn. For traders, this presents a short-term opportunity in CAL due to the strong earnings beat and upward guidance revision, potentially indicating a re-evaluation of the company's intrinsic value. The long-term implications depend on whether Caleres can sustain this growth trajectory. The filing also lists several other companies that saw significant gains on the same day due to their own positive corporate news, highlighting that individual company performance can buck broader market trends.

$CAL positive Beat Q2 earnings and sales, raised FY26 EPS guidance
$IRD positive Positive clinical trial results
$SIG positive Beat Q2 earnings, raised FY27 adjusted EPS guidance
$ODD positive Beat Q2 earnings, strong guidance
$FTK positive Raised 2026 guidance
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.